Psychological and Neuropsychological Testing Criteria
Customize your policy alerts
Sign up for lucet Policy 20.5.004 alerts
Get alerted when Policy 20.5.004 changes without checking for updates manually.
Monitor payer policy activity
Defines medical necessity, limitations, and expectations for psychological and neuropsychological testing for members when tests inform diagnosis, prognosis, or treatment planning; applies to providers requesting/performing testing under lucet benefit plans.
Added 2 references and updated summary of evidence and description of treatment.
Added criteria for psychological testing and neuropsychological testing, limitations of coverage, and expectations of treatment; updated summary of evidence.
Coverage Criteria — Psychological & Neuropsychological Testing
Medical necessity criteria
Covered when ONE OR MORE of the following indications are met:
Derived from section A items 1-9
Derived from section B items 1-8 and section B items 4-8
Psychological and neuropsychological testing is excluded when the patient is neurologically, cognitively, or psychologically unable to participate meaningfully in the testing process. Coverage is also excluded when there is no reasonable expectation that the patient will benefit from therapeutic or care options (i.e., testing will not inform medical or psychological management). Routine use of tests as a population screening tool without a clinical justification is excluded, as are tests administered for purely educational, vocational, or other non-clinical purposes that do not inform medical or health management.
Testing that consists exclusively of self-administered, self-created, or self-scored inventories, or that is comprised solely of screening instruments (for example, brief cognitive screens such as the Folstein Mini‑Mental State Examination), is considered not reasonable and necessary and is excluded. Also excluded is testing or repeat testing that will not influence medical or behavioral management decisions (for example, repeat testing requested by a patient without clinical justification) and testing administered while the patient is acutely impaired by substances.
Referenced Coding Guidance
| No codes listed |
Provider Actions, Documentation & Exceptions
Exceptions and resources — CMO approval required
Exceptions to this medical policy must be approved by the Chief Medical Officer or their designee. Related resources include the Psychological‑Neuropsychological Testing (PNT) WebPass Guide and state-specific guides listed under GUIDES / HANDOUTS; a Request for Psychological/Neuropsychological Testing form is available for submissions.
- Exceptions require approval by the Chief Medical Officer or designee.
- See PNT WebPass Guide and state-specific testing guides for request processes.
- Use the Request for Psychological/Neuropsychological Testing form when submitting requests.
Provider actions — authorization and routing
Submit requests using the Request for Psychological/Neuropsychological Testing form and ensure authorization routing follows the payer's WebPass/guide instructions; testing must meet the medical necessity criteria in the policy and be ordered by a qualified provider.
- Complete an initial face-to-face diagnostic assessment before requesting testing.
- Use the standardized Request for Psychological/Neuropsychological Testing form for authorization.
- Ensure the requested battery and indications align with the policy's medical necessity criteria.
Required documentation and reporting
An initial face-to-face complete diagnostic assessment is required prior to testing; at completion produce a comprehensive report that includes the tests administered, scores, and an in‑depth summary of findings.
- Document the initial face-to-face diagnostic assessment that identifies specific diagnostic/clinical questions.
- Final report must list tests used, raw/standard scores, and an in‑depth interpretation tying results to management.
- Retain and submit the Request for Psychological/Neuropsychological Testing form when applicable.
Triggers for denial / not reasonable and necessary
Testing is not reasonable and necessary — and may be denied — when it is used as routine screening without clinical justification, administered for non‑clinical (educational/vocational) purposes, comprised exclusively of self‑administered or screening instruments, when the patient cannot participate meaningfully, when testing will not affect management, when the patient is under the influence of substances, or during acute delirium/psychosis.
- Routine population screening or tests lacking a medical/psychological rationale.
- Exclusively self‑administered, self‑scored, or screening-only batteries (e.g., Folstein MMSE).
- Patient unable to participate meaningfully, under substance influence, or experiencing acute delirium/psychosis.
- Repeat testing requested without clinical justification or when prior diagnosis makes testing irrelevant to management.
Definitions
Background
Psychological testing is used to evaluate functional strengths, psychopathology, psychodynamics, risk, insight, motivation, and other factors that influence diagnosis, treatment planning, prognosis, and the delivery of care. Neuropsychological testing is performed to assess cognitive and neurobehavioral functioning in patients with known or suspected neurological, medical, or developmental conditions (for example, brain injury, neurodegenerative disease, autism spectrum disorder, or learning disorders) to inform diagnosis, establish baseline or treatment-related cognitive status, guide rehabilitation, and support clinical decision-making.
Document History & Revisions
Added 2 references, removed 1 reference, updated the summary of evidence, and added a description of treatment.
Expanded criteria by adding psychological and neuropsychological testing sections, added limitations of coverage and expectations of treatment, and updated the summary of evidence with reference updates.
Initial review/new policy entry recorded.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.